Dialogues on Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities

September 22-23, 2011
Washington, DC

SWHR and the FDA Office of Women's Health hosted a two-day conference to share successful practices in recruitment, retention and analysis of women and minorities in clinical trials.

Left to Right: Phyllis Greenberger, MSW, Margaret Hamburg, MD,
Marsha Henderson, MCRP, Michelle Yeboah, DrPH

The executive summary from this conference was published in the July 2012 issue of the Journal of Women’s Health. Read More

View the Agenda

Read the Press Release

Read the White Paper

View the Webcast of Day 1

View the Webcast of Day 2

View the Webcast of FDA Commissioner Margaret Hamburg

Plenary 1: Women & Minorities in Clinical Trial Research: A Historical Overview

• Stephen Thomas, PhD, University of Maryland
  View Slides

• Kenneth Getz, MBA, CISCRP, Tufts University
  View Slides

Panel 1: Provider/Investigator Perspectives on Cultural and Linguistic Competency in Clinical Trials Research

• E. Francis Jones, Innovative Clinical Concepts, LLC
  View Slides

• James Powell, MD, Project IMPACT
  View Slides

• Lillian Tom-Orme, PhD, University of Utah
  View Slides

• James P. Tierney, MA, MBA, Interamerican College of Physicians and Surgeons, Inc.
  View Slides

Panel 2: The Vital Role of Communities in Clinical Trials

• Pat Sanders, P&E Associates
  View Slides

• Judith Fifield, PhD, University of Connecticut, Vanderbilt University
  View Slides

• Jeffrey Henderson, MD, MPH, Black Hills Center for American Indian Health

• Daniel C. Montoya (National Minority AIDS Council
  View Slides

Lunch: Beyond the Ivory Tower: Clinical Trials for All

• Zora Brown, INTEGRIS Health

• Gary Puckrein, PhD, National Minority Quality Forum
  View Slides

• Coleman K. Obasaju, MD, PhD, Eli Lilly
  View Slides

Panel 3: Strategies in Clinical Trials: Research Design for Recruitment, Retention, Analysis

• Armin Weinberg, PhD, Life Beyond Cancer Foundation
  View Slides

• Joseph Mrus, MD, MSc, Janssen Services, LLC
  View Slides

• Alfonso J. Alanis, MD, Anaclim, LLC
  View Slides

Panel 4: Federal Perspectives on the Inclusion of Women and Minorities in Clinical Trials

• Ameeta Parekh, PhD, FDA, OWH
  View Slides

• Kathryn O’Callaghan, FDA, CDRH
  View Slides

• Patrice Desvigne-Nickens, MD, NIH, NHLBI
  View Slides

Plenary 2: Federal Perspectives on Clinical Regulatory Research Innovations

• Vicki L. Seyfert-Margolis, PhD, FDA
  View Slides

• Garry Neil, MD, J&J

Speaker Biographies

###

This conference is made possible by the generous support of:

AstraZeneca
Baxter Healthcare
Boehringer Ingelheim Pharmaceuticals, Inc.
Boston Scientific Corporation
Cardinal Health
Cephalon, Inc.
Eli Lilly and Company
Genentech, a member of the Roche Group
GlaxoSmithKline
Johnson & Johnson
Merck & Co, Inc.
Novartis Pharmaceutical Company
Pfizer Inc.

###

A special thank you to the FDA Office of Minority Health for their support and assistance.